• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗伊斯兰共和国2型糖尿病患病率:系统评价与荟萃分析

Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis.

作者信息

Haghdoost A A, Rezazadeh-Kermani M, Sadghirad B, Baradaran H R

机构信息

Physiology Research Centre, Kerman University of Medical Sciences, Kerman, Islamic Republic of Iran.

出版信息

East Mediterr Health J. 2009 May-Jun;15(3):591-9.

PMID:19731775
Abstract

We estimated the prevalence of type 2 diabetes in the Islamic Republic of Iran by systematic review of all available studies in the country between 1996 and 2004 and aggregation of the data using meta-analysis and meta-regression methods. In those > 40 years the prevalence was 24% and it increased by 0.4% with each year after 20 years of age. The risk of type 2 diabetes was 1.7% greater in women than men (P < 0.001). The prevalence of type 2 diabetes appears higher in the Islamic Republic of Iran than in other developing countries but because of differences in age pyramids, the crude prevalence is not an appropriate indicator and age-adjusted or age-specific prevalences should be used.

摘要

我们通过系统回顾1996年至2004年间伊朗伊斯兰共和国所有可得研究,并运用荟萃分析和荟萃回归方法汇总数据,估算了该国2型糖尿病的患病率。在40岁以上人群中,患病率为24%,且在20岁以后,患病率每年增加0.4%。女性患2型糖尿病的风险比男性高1.7%(P<0.001)。伊朗伊斯兰共和国的2型糖尿病患病率似乎高于其他发展中国家,但由于年龄金字塔结构的差异,粗患病率并非合适的指标,应使用年龄调整患病率或年龄特异性患病率。

相似文献

1
Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis.伊朗伊斯兰共和国2型糖尿病患病率:系统评价与荟萃分析
East Mediterr Health J. 2009 May-Jun;15(3):591-9.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.糖皮质激素性骨质疏松症:一项系统评价与成本效用分析
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. doi: 10.3310/hta11070.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
8
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
An Early View of Iran Primary Sjogren Syndrome Registry (Guilan Province Pilot Phase), an Emerging Effort for a National Registry Establishment.伊朗原发性干燥综合征登记处的早期情况(吉兰省试点阶段),这是建立国家登记处的一项新举措。
Med J Islam Repub Iran. 2024 Nov 19;38:134. doi: 10.47176/mjiri.38.134. eCollection 2024.
2
Host Risk Factors for Tuberculosis.结核病的宿主风险因素。
Infect Disord Drug Targets. 2025;25(4):e18715265304343. doi: 10.2174/0118715265304343240722190414.
3
Depression literacy, mental health literacy, and their relationship with psychological status and quality of life in patients with type 2 diabetes mellitus.
2 型糖尿病患者的抑郁知识、精神卫生知识及其与心理状态和生活质量的关系。
Front Public Health. 2024 Jul 11;12:1421053. doi: 10.3389/fpubh.2024.1421053. eCollection 2024.
4
An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996-2023.一项关于伊朗 1996 年至 2023 年 2 型糖尿病患病率的更新系统评价和荟萃分析。
Front Public Health. 2024 Apr 4;12:1322072. doi: 10.3389/fpubh.2024.1322072. eCollection 2024.
5
Exploring determinants of sex and family history-based disparity in type 2 diabetes mellitus prevalence among clinical patients.探讨临床患者 2 型糖尿病患病率中基于性别和家族史的差异的决定因素。
BMC Public Health. 2024 Mar 4;24(1):682. doi: 10.1186/s12889-024-18170-0.
6
The effect of diabetes training through social networks on metabolic control of individuals with type 2 diabetes; a randomized controlled trial.通过社交网络对 2 型糖尿病患者进行糖尿病培训对代谢控制的影响:一项随机对照试验。
J Prev Med Hyg. 2024 Jan 1;64(4):E499-E506. doi: 10.15167/2421-4248/jpmh2023.64.4.3158. eCollection 2023 Dec.
7
Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.伊朗非酒精性脂肪性肝病的患病率:一项系统评价与荟萃分析
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101209. doi: 10.1016/j.jceh.2023.06.009. Epub 2023 Jun 29.
8
Letter to the editor: alarming prevalence of comorbid conditions in adults with type 2 diabetes in Iran.致编辑的信:伊朗2型糖尿病成年患者中合并症的惊人患病率。
J Diabetes Metab Disord. 2023 Jul 14;22(2):1809-1811. doi: 10.1007/s40200-023-01254-w. eCollection 2023 Dec.
9
Stem cell transplantation therapy for diabetic foot ulcer: a narrative review.糖尿病足溃疡的干细胞移植治疗:一项叙述性综述。
Asian Biomed (Res Rev News). 2021 Feb 21;15(1):3-18. doi: 10.2478/abm-2021-0002. eCollection 2021 Feb.
10
Prevalence of Diabetes Mellitus and its Related Factors in Patients with Tuberculosis.结核病患者中糖尿病的患病率及其相关因素。
Arch Iran Med. 2022 Dec 1;25(12):835-840. doi: 10.34172/aim.2022.129.